These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3450191)

  • 1. Chromosome and xanthone derivatives related to Fostedil.
    Chiarini A; Valenti P; Fabbri G; da Re P
    Acta Pharm Suec; 1987; 24(5):257-62. PubMed ID: 3450191
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of the diethyl phosphonate group to a first approach of calcium-inhibiting activity: study of a series of various substituted 2-phenylbenzothiazoles.
    Mouysset G; de Saqui-Sannes G; Younes S; Bellan J; Payard M; Tisne-Versailles J
    Farmaco; 1990 Sep; 45(9):945-52. PubMed ID: 2282126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New thiazolo[3,2-a] pyrimidine derivatives, synthesis and calcium antagonistic activities.
    Balkan A; Tozkoparan B; Ertan M; Sara Y; Ertekin N
    Boll Chim Farm; 1996 Dec; 135(11):648-52. PubMed ID: 9138461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic phosphorus compounds. IV. Asymmetric 4-(benzothiazol-2-yl)benzylphosphonates as potent calcium antagonistic vasodilators.
    Yoshino K; Goto K; Kohno T; Morita T; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):676-80. PubMed ID: 2347009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic phosphorus compounds. 5. (4-Benzothiazol-2-ylbenzyl)amidophosphonate as potent calcium antagonistic vasodilators.
    Yoshino K; Goto K; Yoshiizumi K; Morita T; Tsukamoto G
    J Med Chem; 1990 Aug; 33(8):2192-6. PubMed ID: 2374146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. -Adrenergic blocking agents of the chromone and xanthone groups.
    Da Re P; Valenti P; Borraccini A; Primofiore GP
    J Med Chem; 1972 Feb; 15(2):198-9. PubMed ID: 4400150
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antimycobacterial activity of some new 3-heterocyclic substituted chromones.
    Gasparová R; Lácová M; el-Shaaer HM; Odlerová Z
    Farmaco; 1997 Apr; 52(4):251-3. PubMed ID: 9241831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacology of KB-944, a new calcium antagonist.
    Morita T; Fukuda T; Sukamoto T; Tajima S; Sato I; Ikeda Y; Kanazawa T; Hamada Y; Morimoto Y; Kitamura H; Kawakami K; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1060-8. PubMed ID: 6890827
    [No Abstract]   [Full Text] [Related]  

  • 9. Thiazolo[3,2-a]pyrimidine derivatives as calcium antagonists.
    Balkan A; Uma S; Ertan M; Wiegrebe W
    Pharmazie; 1992 Sep; 47(9):687-8. PubMed ID: 1475316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac action of KB-944, a new calcium antagonist.
    Morita T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1053-5. PubMed ID: 6890825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of some 4-[3' or 4'-(4H- 4-oxo-1-benzopyran-2-yl)phenyl]-1,4-dihydropyridine derivatives as potential calcium channel antagonists.
    Tunçbilek M; Ertan R
    Pharmazie; 1999 Apr; 54(4):255-9. PubMed ID: 10234737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic phosphorus compounds. 2. Synthesis and coronary vasodilator activity of (benzothiazolylbenzyl) phosphonate derivatives.
    Yoshino K; Kohno T; Morita T; Tsukamoto G
    J Med Chem; 1989 Jul; 32(7):1528-32. PubMed ID: 2738888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the vinyl group on the calcium antagonistic activity of analogues of Fostedil.
    Tchani G; Baziard-Mouysset G; Stigliani JL; Payard M; Bonnafous R; Tisne-Versailles J
    Pharm Acta Helv; 1994 Jan; 68(3):173-9. PubMed ID: 8121926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for new Ca++ antagonists. Lipophilic oximes and phosphonates.
    Bellucci C; Teodori E; Gualtieri F; Piacenza G
    Farmaco Sci; 1985 Oct; 40(10):730-44. PubMed ID: 3002848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic effect of KB-944, a new calcium antagonist. A comparison with verapamil and diltiazem.
    Yoshidomi M; Sukamoto T; Morita T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1056-9. PubMed ID: 6890826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3, 5-di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones.
    Kato T; Ozaki T; Tamura K; Suzuki Y; Akima M; Ohi N
    J Med Chem; 1998 Oct; 41(22):4309-16. PubMed ID: 9784106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and calcium antagonistic activity of (+)-(R)- and (-)-(S)-3-acetyl-2-[5-methoxy-2-[4-[N-methyl-N-(3,4,5- trimethoxyphenethyl)amino]butoxy]phenyl]benzothiazoline hydrochloride.
    Fujita M; Ota A; Ito S; Yamamoto K; Kawashima Y; Iso T; Iwao J
    Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):936-41. PubMed ID: 2379287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca-antagonistic activity of some 1,4-piperazine derivatives.
    Seginko J; Dobrocký P; Cagánová B
    Pharmazie; 1995 May; 50(5):368-9. PubMed ID: 7604073
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.